Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-23
1989-04-11
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 69, A61K 3148, C07D45704
Patent
active
048207136
ABSTRACT:
Ketoalkyl esters of 1-substituted-6-C.sub.1-4 straight chain alkyl (or allyl)ergoline-8.beta.-carboxylic acid, useful as 5HT receptor antagonists.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3183234 (1965-05-01), Garbrecht and Lin
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
Cohen et al., J.P.E.T., 227, 327 (1983) (Cohen I).
Cohen et al., ibid, 232, 770 (1984) (Cohen II).
Lemberger et al., Life Sci., 35, 71 (1984).
Cohen et al., Drug Dev. Res., 5, 313 (1985) (Cohen IV).
Hingten et al., Abstract 37.4, Soc. for Neurosci. (13th Annual Meeting, Nov., 1983).
Garbrecht William L.
Marzoni Gifford P.
Conrad Robert A.
Daus Donald G.
Eli Lilly and Company
Shen Cecilia
Whitaker Leroy
LandOfFree
Ketoalkanol esters of dihydrolysergic acid useful as 5HT recepto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ketoalkanol esters of dihydrolysergic acid useful as 5HT recepto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketoalkanol esters of dihydrolysergic acid useful as 5HT recepto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-667441